RISK FACTORS FOR CARDIOVASCULAR EVENTS IN PATIENTS WITH CANCER TREATED WITH PONATINIB

被引:0
|
作者
Pei, Dorothy [1 ]
Ulhaq, Owais [1 ]
Go, Rafael [1 ]
Ali, Abdelrahman [1 ]
Khalaf, Shaden [1 ]
Hamzeh, Ihab [1 ]
Koutroumpakis, Efstratios [1 ]
Iliescu, Cezar [1 ]
Deswal, Anita [1 ]
Palaskas, Nicolas L. [1 ]
机构
[1] MD Anderson Canc Ctr, Houston, TX USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1252-044
引用
收藏
页码:2204 / 2204
页数:1
相关论文
共 50 条
  • [21] What is the risk of cardiovascular events in osteoporotic patients treated with romosozumab?
    Reid, I. R.
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (12) : 1441 - 1443
  • [22] Factors determining long term survival and risk of cardiovascular events in patients treated with subclavian artery angioplasty
    Wrotniak, L.
    Przewlocki, T.
    Kablak-Ziembicka, A.
    Pieniazek, P.
    Roslawiecka, A.
    Musialek, P.
    Kozanecki, A.
    Tekieli, L.
    Podolec, P.
    EUROPEAN HEART JOURNAL, 2013, 34 : 58 - 58
  • [23] Cardiovascular risk factors and impact on cardiovascular events
    Rizzoni, Damiano
    Tocci, Giuliano
    Muiesan, Maria Lorenza
    GIORNALE ITALIANO DI CARDIOLOGIA, 2021, 22 (05) : E24 - E26
  • [24] Risk factors in hypertensive patients without previous cardiovascular events
    de la Sierra, Alejandro
    Gonzalez-Segura, Diego
    MEDICINA CLINICA, 2011, 136 (13): : 559 - 564
  • [25] Modifiable risk factors and incident cardiovascular events in gout patients
    Ning, Y.
    Tang, M.
    An, J.
    Zhao, C.
    Zhang, J.
    Gao, W.
    Wei, M.
    Tse, G.
    Chan, J.
    Waintraub, X.
    Lei, X.
    Saguner, A.
    Yan, Y.
    Wang, D.
    Li, G.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [26] Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular disease
    Hageman, Steven H. J.
    de Borst, Gert Jan
    Dorresteijn, Johannes A. N.
    Bots, Michiel L.
    Westerink, Jan
    Asselbergs, Folkert W.
    Visseren, Frank L. J.
    HEART, 2020, 106 (21) : 1686 - 1692
  • [27] Development of a Risk Score for Cardiovascular Events in Anthracycline Treated DLBCL Patients
    Diamond, Akiva
    Ayyappan, Sabarish
    Cao, Shufen
    Tashtish, Nour
    Boughan, Kirsten M.
    Cooper, Brenda W.
    Fu, Pingfu
    Caimi, Paolo F.
    BLOOD, 2021, 138
  • [28] Analysis of haematological risk factors for thromboembolic events in anaemic cancer patients treated with epoetin beta
    Aapro, M.
    Boogaerts, M.
    Coiffier, B.
    Hayward, C.
    Burger, H.
    EJC SUPPLEMENTS, 2005, 3 (02): : 386 - 386
  • [29] Traditional Cardiovascular Risk Factors and Individual Prediction of Cardiovascular Events in Childhood Cancer Survivors
    Chen, Yan
    Chow, Eric J.
    Oeffinger, Kevin C.
    Border, William L.
    Leisenring, Wendy M.
    Meacham, Lillian R.
    Mulrooney, Daniel A.
    Sklar, Charles A.
    Stovall, Marilyn
    Robison, Leslie L.
    Armstrong, Gregory T.
    Yasui, Yutaka
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (03): : 256 - 265
  • [30] Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study
    Zanchetti, A
    Hansson, L
    Dahlöf, B
    Elmfeldt, D
    Kjeldsen, S
    Kolloch, R
    Larochelle, P
    McInnes, GT
    Mallion, JM
    Ruilope, L
    Wedel, H
    JOURNAL OF HYPERTENSION, 2001, 19 (06) : 1149 - 1159